Lung disease caused by nontuberculous mycobacteria

Area of Science:

• Pulmonary Medicine
• Infectious Diseases
• Microbiology

Background:

• Tuberculosis incidence is declining in developed nations, shifting focus to nontuberculous mycobacteria (NTM) as a significant cause of lung disease.
• Existing research on NTM lung disease primarily focuses on Mycobacterium avium complex, Mycobacterium kansasii, and Mycobacterium abscessus, often based on retrospective data from developed countries.
• Recent advancements have introduced new insights into other NTM species and their pathogenesis.

Purpose of the Study:

• To review current understanding of NTM lung disease, highlighting emerging species and challenges in diagnosis.
• To underscore the need for updated diagnostic criteria and further research into NTM pathogenesis and treatment.

Main Methods:

• Review of recent epidemiological studies on NTM infections worldwide.
• Analysis of new findings concerning specific NTM species (e.g., Mycobacterium fortuitum, Mycobacterium xenopi).
• Evaluation of existing diagnostic criteria in light of new species data.

Main Results:

• NTM infections are a global issue, with increasing prevalence in developing countries, potentially linked to water systems.
• Specific populations, including women with a characteristic phenotype and patients with cystic fibrosis transmembrane conductance regulator defects, are at higher risk.
• Current American Thoracic Society diagnostic criteria may be inadequate for certain NTM species.

Conclusions:

• Multicenter, prospective studies are essential to elucidate the pathogenesis and optimal treatment strategies for NTM lung disease.
• The heterogeneity of NTM necessitates individual species-specific research and diagnostic approaches.